Uric acid and contrast-induced nephropathy: An updated review and meta-regression analysis

Francesco Pelliccia, Vincenzo Pasceri, Giuseppe Patti, Giuseppe Marazzi, Giuseppe De Luca, Gaetano Tanzilli, Nicola Viceconte, Giulio Speciale, Enrico Mangieri, Carlo Gaudio

Research output: Contribution to journalArticle

Abstract

Introduction: Previous studies have suggested a relationship between serum uric acid and contrast-induced nephropathy (CIN). Aim: We performed an updated review and a meta-regression analysis to assess whether serum uric acid is associated with CIN or there exists any relationship between serum uric acid and other risk factors for CIN. Material and methods: We searched PubMed, Embase and Cochrane databases and reviewed cited references up to July 31, 2018 to identify relevant studies. Results: A total of 6,705 patients from 10 clinical studies were included. CIN occurred in 774 of the 6,705 (12%) patients. Baseline uric acid levels were significantly higher in those who developed CIN (6.51 vs. 5.67 mg/dl; 95% CI: 0.55-1.22, p = 0.00001). Comparison of clinical features showed that patients with CIN were significantly older (69 vs. 63 years; p < 0.00001) and more often had diabetes (42% vs. 32%; p = 0.002) and hypertension (67% vs. 59%; p = 0.03). Also, patients who developed CIN had lower hemoglobin (12.5 vs. 13.6 mg/dl; p < 0.00001) and higher levels of baseline creatinine (1.27 vs. 1.01 mg/dl; p < 0.0001), but had similar levels of glycemia, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglyceride. Also, they showed a lower ejection fraction (45% vs. 50%; p < 0.00001). Meta-regression analysis revealed that uric acid related only to age (r = 0.13, p = 0.03). Conclusions: Our investigation indicates that uric acid is significantly associated with CIN. Uric acid correlated significantly with age only, and not with other major predictors of CIN. Further studies are therefore needed to verify the potential of uric acid to improve CIN risk stratification.

Original languageEnglish
Pages (from-to)399-412
Number of pages14
JournalPostepy w Kardiologii Interwencyjnej
Volume14
Issue number4
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Uric Acid
Meta-Analysis
Regression Analysis
Serum
PubMed
LDL Cholesterol
HDL Cholesterol
Creatinine
Hemoglobins
Cholesterol
Databases
Hypertension

Keywords

  • Angiography
  • Contrast-induced nephropathy
  • Percutaneous coronary intervention
  • Uric acid

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Uric acid and contrast-induced nephropathy : An updated review and meta-regression analysis. / Pelliccia, Francesco; Pasceri, Vincenzo; Patti, Giuseppe; Marazzi, Giuseppe; De Luca, Giuseppe; Tanzilli, Gaetano; Viceconte, Nicola; Speciale, Giulio; Mangieri, Enrico; Gaudio, Carlo.

In: Postepy w Kardiologii Interwencyjnej, Vol. 14, No. 4, 01.01.2018, p. 399-412.

Research output: Contribution to journalArticle

Pelliccia, F, Pasceri, V, Patti, G, Marazzi, G, De Luca, G, Tanzilli, G, Viceconte, N, Speciale, G, Mangieri, E & Gaudio, C 2018, 'Uric acid and contrast-induced nephropathy: An updated review and meta-regression analysis', Postepy w Kardiologii Interwencyjnej, vol. 14, no. 4, pp. 399-412. https://doi.org/10.5114/aic.2018.79870
Pelliccia, Francesco ; Pasceri, Vincenzo ; Patti, Giuseppe ; Marazzi, Giuseppe ; De Luca, Giuseppe ; Tanzilli, Gaetano ; Viceconte, Nicola ; Speciale, Giulio ; Mangieri, Enrico ; Gaudio, Carlo. / Uric acid and contrast-induced nephropathy : An updated review and meta-regression analysis. In: Postepy w Kardiologii Interwencyjnej. 2018 ; Vol. 14, No. 4. pp. 399-412.
@article{b053bdd01b9c463eb10b824523244e4d,
title = "Uric acid and contrast-induced nephropathy: An updated review and meta-regression analysis",
abstract = "Introduction: Previous studies have suggested a relationship between serum uric acid and contrast-induced nephropathy (CIN). Aim: We performed an updated review and a meta-regression analysis to assess whether serum uric acid is associated with CIN or there exists any relationship between serum uric acid and other risk factors for CIN. Material and methods: We searched PubMed, Embase and Cochrane databases and reviewed cited references up to July 31, 2018 to identify relevant studies. Results: A total of 6,705 patients from 10 clinical studies were included. CIN occurred in 774 of the 6,705 (12{\%}) patients. Baseline uric acid levels were significantly higher in those who developed CIN (6.51 vs. 5.67 mg/dl; 95{\%} CI: 0.55-1.22, p = 0.00001). Comparison of clinical features showed that patients with CIN were significantly older (69 vs. 63 years; p < 0.00001) and more often had diabetes (42{\%} vs. 32{\%}; p = 0.002) and hypertension (67{\%} vs. 59{\%}; p = 0.03). Also, patients who developed CIN had lower hemoglobin (12.5 vs. 13.6 mg/dl; p < 0.00001) and higher levels of baseline creatinine (1.27 vs. 1.01 mg/dl; p < 0.0001), but had similar levels of glycemia, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglyceride. Also, they showed a lower ejection fraction (45{\%} vs. 50{\%}; p < 0.00001). Meta-regression analysis revealed that uric acid related only to age (r = 0.13, p = 0.03). Conclusions: Our investigation indicates that uric acid is significantly associated with CIN. Uric acid correlated significantly with age only, and not with other major predictors of CIN. Further studies are therefore needed to verify the potential of uric acid to improve CIN risk stratification.",
keywords = "Angiography, Contrast-induced nephropathy, Percutaneous coronary intervention, Uric acid",
author = "Francesco Pelliccia and Vincenzo Pasceri and Giuseppe Patti and Giuseppe Marazzi and {De Luca}, Giuseppe and Gaetano Tanzilli and Nicola Viceconte and Giulio Speciale and Enrico Mangieri and Carlo Gaudio",
year = "2018",
month = "1",
day = "1",
doi = "10.5114/aic.2018.79870",
language = "English",
volume = "14",
pages = "399--412",
journal = "Postepy w Kardiologii Interwencyjnej",
issn = "1734-9338",
publisher = "Termedia Publishing House Ltd.",
number = "4",

}

TY - JOUR

T1 - Uric acid and contrast-induced nephropathy

T2 - An updated review and meta-regression analysis

AU - Pelliccia, Francesco

AU - Pasceri, Vincenzo

AU - Patti, Giuseppe

AU - Marazzi, Giuseppe

AU - De Luca, Giuseppe

AU - Tanzilli, Gaetano

AU - Viceconte, Nicola

AU - Speciale, Giulio

AU - Mangieri, Enrico

AU - Gaudio, Carlo

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Introduction: Previous studies have suggested a relationship between serum uric acid and contrast-induced nephropathy (CIN). Aim: We performed an updated review and a meta-regression analysis to assess whether serum uric acid is associated with CIN or there exists any relationship between serum uric acid and other risk factors for CIN. Material and methods: We searched PubMed, Embase and Cochrane databases and reviewed cited references up to July 31, 2018 to identify relevant studies. Results: A total of 6,705 patients from 10 clinical studies were included. CIN occurred in 774 of the 6,705 (12%) patients. Baseline uric acid levels were significantly higher in those who developed CIN (6.51 vs. 5.67 mg/dl; 95% CI: 0.55-1.22, p = 0.00001). Comparison of clinical features showed that patients with CIN were significantly older (69 vs. 63 years; p < 0.00001) and more often had diabetes (42% vs. 32%; p = 0.002) and hypertension (67% vs. 59%; p = 0.03). Also, patients who developed CIN had lower hemoglobin (12.5 vs. 13.6 mg/dl; p < 0.00001) and higher levels of baseline creatinine (1.27 vs. 1.01 mg/dl; p < 0.0001), but had similar levels of glycemia, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglyceride. Also, they showed a lower ejection fraction (45% vs. 50%; p < 0.00001). Meta-regression analysis revealed that uric acid related only to age (r = 0.13, p = 0.03). Conclusions: Our investigation indicates that uric acid is significantly associated with CIN. Uric acid correlated significantly with age only, and not with other major predictors of CIN. Further studies are therefore needed to verify the potential of uric acid to improve CIN risk stratification.

AB - Introduction: Previous studies have suggested a relationship between serum uric acid and contrast-induced nephropathy (CIN). Aim: We performed an updated review and a meta-regression analysis to assess whether serum uric acid is associated with CIN or there exists any relationship between serum uric acid and other risk factors for CIN. Material and methods: We searched PubMed, Embase and Cochrane databases and reviewed cited references up to July 31, 2018 to identify relevant studies. Results: A total of 6,705 patients from 10 clinical studies were included. CIN occurred in 774 of the 6,705 (12%) patients. Baseline uric acid levels were significantly higher in those who developed CIN (6.51 vs. 5.67 mg/dl; 95% CI: 0.55-1.22, p = 0.00001). Comparison of clinical features showed that patients with CIN were significantly older (69 vs. 63 years; p < 0.00001) and more often had diabetes (42% vs. 32%; p = 0.002) and hypertension (67% vs. 59%; p = 0.03). Also, patients who developed CIN had lower hemoglobin (12.5 vs. 13.6 mg/dl; p < 0.00001) and higher levels of baseline creatinine (1.27 vs. 1.01 mg/dl; p < 0.0001), but had similar levels of glycemia, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglyceride. Also, they showed a lower ejection fraction (45% vs. 50%; p < 0.00001). Meta-regression analysis revealed that uric acid related only to age (r = 0.13, p = 0.03). Conclusions: Our investigation indicates that uric acid is significantly associated with CIN. Uric acid correlated significantly with age only, and not with other major predictors of CIN. Further studies are therefore needed to verify the potential of uric acid to improve CIN risk stratification.

KW - Angiography

KW - Contrast-induced nephropathy

KW - Percutaneous coronary intervention

KW - Uric acid

UR - http://www.scopus.com/inward/record.url?scp=85058713805&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058713805&partnerID=8YFLogxK

U2 - 10.5114/aic.2018.79870

DO - 10.5114/aic.2018.79870

M3 - Article

AN - SCOPUS:85058713805

VL - 14

SP - 399

EP - 412

JO - Postepy w Kardiologii Interwencyjnej

JF - Postepy w Kardiologii Interwencyjnej

SN - 1734-9338

IS - 4

ER -